Growth hormone deficiency – childhood onset or adult onset

The Pharmaceutical Benefits Scheme (PBS) subsidises somatropin for childhood onset or adult onset severe growth hormone deficiency.

Patient eligibility

Patients must be eligible for the PBS and meet the relevant restriction criteria.

The Schedule of Pharmaceutical Benefits on the PBS website outlines restrictions for prescribing somatropin.

Treatment specifics

Patients must be treated by an endocrinologist for initial treatment, as well as for continuing treatment, to be eligible for PBS subsidised treatment with somatropin.

Applications

Initial treatment

Apply for initial authority approval to prescribe PBS subsidised somatropin for severe growth hormone deficiency in writing and either:

All applications must include the completed:

Continuing treatment

Apply for authority approval to continue PBS subsidised somatropin to treat severe growth hormone deficiency in writing and either:

All applications must include the completed:

More information

Call the PBS Complex Drugs Programs enquiry line for more information.

Page last updated: 19 December 2019